The clinical significance of HER2 amplification lies in its impact on treatment decisions and prognosis. Patients with HER2-positive cancers are often eligible for targeted therapies that specifically inhibit the HER2 receptor. These therapies can significantly improve outcomes in those with HER2-amplified tumors. Furthermore, HER2 amplification serves as a prognostic marker, indicating a more aggressive cancer phenotype.
